STOP (Successful Treatment Of Paranoia) is a patient-facing app that aims to reduce clinical symptoms of paranoia, in patients with mild to moderate paranoia. It is a self-administered 12-week programme using Cognitive Bias Modification for Interpretation therapy (CBM-I). Avegen in collaboration with King’s College London designed and set up STOP, the smartphone version of the therapy.
Klick is a digitally-enabled HIV care pathway conceptualised by Chelsea and Westminster Hospital Foundation Trust (CWFT), Avegen and a major pharmaceutical company. Klick was designed and built by Avegen to integrate with and enhance CWFT’s outpatient service model, whilst delivering a positive experience for patients.